STOCK TITAN

Spruce Biosciences to Present at Upcoming Investor Conferences in March

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags
conferences

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, today announced that Javier Szwarcberg, M.D., M.P.H., Chief Executive Officer, will present at two upcoming investor conferences taking place in March.

  • Leerink Global Healthcare Conference
    Date and Time: March 9, 2026, at 11:20 a.m. ET
    Format: Fireside chat and 1x1 meetings
    Location: Miami, FL
  • The Citizens Life Sciences Conference
    Date and Time: March 10, 2026, at 12:30 p.m. ET
    Format: Fireside chat and 1x1 meetings
    Location: Miami, FL

Interested parties can access the live webcasts for each conference on the events section of the Company’s website. An archived copy of the webcasts will be available for approximately 90 days.

About Spruce Biosciences

Spruce Biosciences is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need. To learn more, visit www.sprucebio.com and follow us on X, LinkedIn, Facebook and YouTube.

Media

Carolyn Hawley

Inizio Evoke Comms

Carolyn.Hawley@inizioevoke.com

media@sprucebio.com

Investors

Monique Kosse

Gilmartin Group

Monique@GilmartinIR.com

investors@sprucebio.com

Source: Spruce Biosciences, Inc.

Spruce Biosciences, Inc.

NASDAQ:SPRB

SPRB Rankings

SPRB Latest News

SPRB Latest SEC Filings

SPRB Stock Data

58.81M
971.52k
Pharmaceutical Preparations
Link
United States
SOUTH SAN FRANCISCO